Literature DB >> 7016888

Autonomous cortisol secretion by a metastatic Leydig cell carcinoma associated with Klinefelter's syndrome.

K Knyrim, M Higi, D K Hossfeld, S Seeber, C G Schmidt.   

Abstract

We present the case of a 39-year-old man with Klinefelter's syndrome and a metastatic Leydig cell carcinoma in whom autonomous cortisol production induced by the interstitial cell tumor was found. Apart from the Cushing's syndrome the endocrine activity of the tumor was demonstrated by the secretion of estradiol, estrone, alkaline phosphatase, and testosterone. This is, to our knowledge, the first description of a Cushing's syndrome not caused via ACTH production but directly induced by ectopic steroid production. While being resistent to chemotherapy and radiation, the tumor responded favorably to treatment with o,p'-DDD. The reduction of tumor size was accompanied by a continuous decrease of serum markers. The etiology of the tumor is discussed in the light of the hormonal derangement caused by the genetic abnormality of Klinefelter's syndrome.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7016888     DOI: 10.1007/bf00405905

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  22 in total

1.  CADMIUM-INDUCED INTERSTITIAL CELL TUMORS IN RATS AND MICE AND THEIR PREVENTION BY ZINC.

Authors:  S A GUNN; T C GOULD; W A ANDERSON
Journal:  J Natl Cancer Inst       Date:  1963-10       Impact factor: 13.506

2.  Cortisol and androgen secretion in a case of Nelson's syndrome with paratesticular tumors: response to cyproheptadine therapy.

Authors:  D T Krieger; E Samojlik; C W Bardin
Journal:  J Clin Endocrinol Metab       Date:  1978-10       Impact factor: 5.958

Review 3.  Humoral syndromes associated with cancer.

Authors:  W D Odell; A R Wolfsen
Journal:  Annu Rev Med       Date:  1978       Impact factor: 13.739

Review 4.  Klinefelter's syndrome and its variants: a hormonal and chromosomal study.

Authors:  C A Paulsen; D L Gordon; R W Carpenter; H M Gandy; W D Drucker
Journal:  Recent Prog Horm Res       Date:  1968

5.  Breast cancer and interstitial-cell tumor in a patient with Klinefelter's syndrome.

Authors:  O G Dodge; A W Jackson; S Muldal
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

6.  Klinefelter syndrome: predisposition to acute non-lymphocytic leukaemia?

Authors:  J P Geraedts; A Mol; E Briët; C A Hartgrink-Groeneveld; G J den Ottolander
Journal:  Lancet       Date:  1980-04-05       Impact factor: 79.321

7.  Malignant interstitial-cell tumor of the testis treated with o,p'-DDD.

Authors:  D Abelson; H Bulaschenko; P R Trommer; A Valdes-Dapena
Journal:  Metabolism       Date:  1966-03       Impact factor: 8.694

8.  Metabolism of testoterone and related steroids in metastatic interstitial cell carcinoma of the testis.

Authors:  M B Lipsett; G A Sarfaty; S H Wilson; C W Bardin; L M Fishman
Journal:  J Clin Invest       Date:  1966-11       Impact factor: 14.808

9.  [Malignant interstitial cell tumor of testis with a marker enzyme (author's transl)].

Authors:  M Higi; N Niederle; M E Scheulen; H J Richter
Journal:  J Cancer Res Clin Oncol       Date:  1979-07-27       Impact factor: 4.553

10.  Studies on an interstitial cell tumor of the testis: formation of cortisol-14C from acetate-1-14C1.

Authors:  L L Engel; G Lanman; R E Scully; D B Villee
Journal:  J Clin Endocrinol Metab       Date:  1966-04       Impact factor: 5.958

View more
  2 in total

1.  Pituitary-like proopiomelanocortin transcripts in human Leydig cell tumors.

Authors:  Y de Keyzer; F Lenne; J F Massias; D Vieau; J P Luton; A Kahn; X Bertagna
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

Review 2.  Leydig cell tumor in a patient with 49,XXXXY karyotype: a review of literature.

Authors:  Salwan Maqdasy; Laura Bogenmann; Marie Batisse-Lignier; Béatrice Roche; Fréderic Franck; Françoise Desbiez; Igor Tauveron
Journal:  Reprod Biol Endocrinol       Date:  2015-07-10       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.